Statement Of Cash Flows [Abstract]

GenSight Biologics S.A. - Filing #879715

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for finance income (cost)
858,000 EUR
8,924,000 EUR
Cash flows from (used in) operations before changes in working capital
21,981,000 EUR
20,611,000 EUR
Increase (decrease) in working capital
4,841,000 EUR
5,567,000 EUR
Adjustments for increase (decrease) in other liabilities
4,428,000 EUR
2,051,000 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from sale or issue of treasury shares
369,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.